JP2018021007A5 - - Google Patents

Download PDF

Info

Publication number
JP2018021007A5
JP2018021007A5 JP2017102939A JP2017102939A JP2018021007A5 JP 2018021007 A5 JP2018021007 A5 JP 2018021007A5 JP 2017102939 A JP2017102939 A JP 2017102939A JP 2017102939 A JP2017102939 A JP 2017102939A JP 2018021007 A5 JP2018021007 A5 JP 2018021007A5
Authority
JP
Japan
Prior art keywords
buffer
aqueous composition
composition according
group
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017102939A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018021007A (ja
JP6590860B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018021007A publication Critical patent/JP2018021007A/ja
Publication of JP2018021007A5 publication Critical patent/JP2018021007A5/ja
Application granted granted Critical
Publication of JP6590860B2 publication Critical patent/JP6590860B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017102939A 2016-05-25 2017-05-24 アトロピン含有水性組成物 Active JP6590860B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201604200P 2016-05-25
SG10201604200P 2016-05-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019168569A Division JP6886502B2 (ja) 2016-05-25 2019-09-17 アトロピン含有水性組成物

Publications (3)

Publication Number Publication Date
JP2018021007A JP2018021007A (ja) 2018-02-08
JP2018021007A5 true JP2018021007A5 (enExample) 2019-08-22
JP6590860B2 JP6590860B2 (ja) 2019-10-16

Family

ID=60411416

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2017102939A Active JP6590860B2 (ja) 2016-05-25 2017-05-24 アトロピン含有水性組成物
JP2019168569A Active JP6886502B2 (ja) 2016-05-25 2019-09-17 アトロピン含有水性組成物
JP2021082578A Active JP7224390B2 (ja) 2016-05-25 2021-05-14 アトロピン含有水性組成物
JP2023016850A Withdrawn JP2023058574A (ja) 2016-05-25 2023-02-07 アトロピン含有水性組成物
JP2025032538A Pending JP2025084921A (ja) 2016-05-25 2025-03-03 アトロピン含有水性組成物
JP2025153045A Withdrawn JP2025176149A (ja) 2016-05-25 2025-09-16 アトロピン含有水性組成物

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2019168569A Active JP6886502B2 (ja) 2016-05-25 2019-09-17 アトロピン含有水性組成物
JP2021082578A Active JP7224390B2 (ja) 2016-05-25 2021-05-14 アトロピン含有水性組成物
JP2023016850A Withdrawn JP2023058574A (ja) 2016-05-25 2023-02-07 アトロピン含有水性組成物
JP2025032538A Pending JP2025084921A (ja) 2016-05-25 2025-03-03 アトロピン含有水性組成物
JP2025153045A Withdrawn JP2025176149A (ja) 2016-05-25 2025-09-16 アトロピン含有水性組成物

Country Status (15)

Country Link
US (3) US20210267885A1 (enExample)
EP (2) EP3463360B2 (enExample)
JP (6) JP6590860B2 (enExample)
KR (4) KR102804061B1 (enExample)
CN (3) CN117205210A (enExample)
AR (1) AR108591A1 (enExample)
CA (1) CA3023149C (enExample)
EA (1) EA201892703A1 (enExample)
ES (1) ES2929368T3 (enExample)
MY (1) MY189774A (enExample)
PH (1) PH12018502421A1 (enExample)
SG (1) SG11201809822SA (enExample)
TW (3) TWI849355B (enExample)
UA (1) UA126195C2 (enExample)
WO (1) WO2017204262A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US11052094B2 (en) 2015-05-29 2021-07-06 Sydnexis, Inc. D2O stabilized pharmaceutical formulations
EP3585386A4 (en) 2017-02-21 2020-12-30 Singapore Health Services PTE Ltd COMPOSITION AND PROCESS FOR PREVENTING OR DELAYING THE ONCE OF MYOPIA INCLUDING ATROPINE
EP3970694A1 (en) 2017-05-11 2022-03-23 Vyluma Inc. Atropine pharmaceutical compositions
CN110934869B (zh) * 2018-09-25 2023-07-04 沈阳兴齐眼药股份有限公司 一种阿托品药物组合物和药盒产品
CN114533652B (zh) * 2018-09-25 2024-12-13 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法和用途
MA52857A (fr) 2019-03-01 2021-04-21 Medivis S R L Formulations ophtalmiques à base d'atropine
CA3189821A1 (en) 2020-08-04 2022-02-10 Santen Pharmaceutical Co., Ltd. Agent for treating myopia, preventing myopia and/or suppressing myopia progression
KR20230087514A (ko) * 2020-10-14 2023-06-16 산텐 세이야꾸 가부시키가이샤 안정한 의약 조성물
PE20231656A1 (es) 2020-11-02 2023-10-17 Trethera Corp Formas cristalinas de un inhibidor de cinasa de desoxicitidina y sus usos
WO2022130337A1 (en) * 2020-12-17 2022-06-23 Sun Pharmaceutical Industries Limited An aqueous sterile solution of atropine for ophthalmic use
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
US20230120997A1 (en) * 2021-10-18 2023-04-20 Ocular Science, Inc. Compositions and methods for myopia control and orthokeratology lenses treatment
CN114129511A (zh) * 2021-12-07 2022-03-04 河南润弘制药股份有限公司 一种具有改进稳定性的硫酸阿托品注射液
JP7884090B2 (ja) * 2022-09-11 2026-07-02 アルコン インク． ベンジルアトロピンを含む水性医薬組成物及びその使用
WO2025018419A1 (ja) 2023-07-20 2025-01-23 センジュ ユーエスエー、インコーポレイテッド 水性液剤
JP7665073B1 (ja) 2024-04-05 2025-04-18 ロート製薬株式会社 容器に収容してなる眼科用組成物
JP7723851B1 (ja) 2024-11-22 2025-08-14 参天製薬株式会社 アトロピン含有水性医薬組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617508B2 (ja) * 1988-02-05 1997-06-04 エーザイ株式会社 安定なジフェンヒドラミン含有水溶液
US5612027A (en) * 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
JP3166002B2 (ja) * 1997-01-27 2001-05-14 日本車輌製造株式会社 自動車の洗浄装置
US20030096831A1 (en) 2000-01-18 2003-05-22 Stone Richard A. Ocular growth and nicotinic antagonists
CN1509172A (zh) * 2001-05-25 2004-06-30 ά����ҩ��˾ 哌仑西平眼用凝胶剂
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
JP2007308398A (ja) * 2006-05-17 2007-11-29 Chang Gung Memorial Hospital 目薬、及びその製造方法
JP2010528010A (ja) * 2007-05-21 2010-08-19 ニューロプティックス コーポレイション アミロイドβ造影剤の眼用製剤およびその使用の方法
CN101327216A (zh) * 2007-06-22 2008-12-24 肖正连 一种硫酸阿托品眼用即型凝胶
WO2012161655A1 (en) * 2011-05-23 2012-11-29 Singapore Health Services Pte Ltd Composition and/or method for reducing and/or preventing myopia progression comprising atropine
US20160009705A1 (en) * 2014-06-24 2016-01-14 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) * 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
CN104983739B (zh) * 2015-06-25 2018-01-16 成都乾坤动物药业股份有限公司 一种多功能药物组合及其制备方法和应用
JP2017102939A (ja) * 2016-12-26 2017-06-08 株式会社プロフィールド オーサリング装置、オーサリング方法、およびプログラム
EP3970694A1 (en) * 2017-05-11 2022-03-23 Vyluma Inc. Atropine pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP2020007356A5 (enExample)
JP7224390B2 (ja) アトロピン含有水性組成物
JP2015527402A5 (enExample)
AR070824A1 (es) Suspensiones para inyeccion intravitrea de triamcinolona acetonido de baja viscosidad, altamente floculadas
JP2014139241A5 (enExample)
JP2013525493A5 (enExample)
NZ609719A (en) Pharmaceutical composition
HRP20150196T1 (hr) Farmaceutske formulacije s ligandima receptora dopamina
RU2013124024A (ru) Фармацевтическая композиция, содержащая мометазона фуроат и азеластина гидрохлорид, назального введения
JP2013513612A5 (enExample)
JP2016534142A5 (enExample)
JP2019081811A5 (enExample)
JP2016512210A5 (enExample)
JP2017002035A5 (enExample)
JP2016503058A5 (enExample)
JP2022511335A5 (enExample)
JP2013535472A5 (enExample)
JP2021191802A5 (enExample)
MX390201B (es) Nueva formulacion que comprende un derivado de bencimidazol
JP2011026350A5 (enExample)
JP2007529458A5 (enExample)
JP5922609B2 (ja) ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性組成物
RU2014115289A (ru) Композиция пазопаниба
JP2014534215A5 (enExample)
JP2021119164A5 (enExample)